TTOO Historical Income Statement
| TTOO Stock | USD 3.72 0.07 1.92% |
Historical analysis of T2 Biosystms income statement accounts such as Research Development of 20.9 M, Cost Of Revenue of 17.9 M, Total Operating Expenses of 43.2 M or Income Tax Expense of 1.2 M can show how well T2 Biosystms performed in making a profits. Evaluating T2 Biosystms income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of T2 Biosystms's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining T2 Biosystms latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether T2 Biosystms is a good buy for the upcoming year.
TTOO |
About TTOO Income Statement Analysis
T2 Biosystms Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to T2 Biosystms shareholders. The income statement also shows TTOO investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
T2 Biosystms Income Statement Chart
T2 Biosystms Income Statement is one of the three primary financial statements used for reporting TTOO's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of T2 Biosystms revenue and expense. T2 Biosystms Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, T2 Biosystms' Total Revenue is very stable compared to the past year. As of the 3rd of May 2024, Other Operating Expenses is likely to grow to about 55.3 M, while Depreciation And Amortization is likely to drop about 843.9 K. Add Fundamental
Interest Expense
The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.Total Revenue
Total revenue comprises all receipts T2 Biosystms generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of T2 Biosystms. It is also known as T2 Biosystms overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Cost Of Revenue
Cost of Revenue is found on T2 Biosystms income statement and represents the costs associated with goods and services T2 Biosystms provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Most accounts from T2 Biosystms' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into T2 Biosystms current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in T2 Biosystms. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.At this time, T2 Biosystms' Total Revenue is very stable compared to the past year. As of the 3rd of May 2024, Other Operating Expenses is likely to grow to about 55.3 M, while Depreciation And Amortization is likely to drop about 843.9 K.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 6.6M | 6.1M | 5.3M | 4.9M | Depreciation And Amortization | 318K | 39K | 859K | 843.9K |
T2 Biosystms income statement Correlations
Click cells to compare fundamentals
T2 Biosystms Account Relationship Matchups
High Positive Relationship
High Negative Relationship
T2 Biosystms income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 400K | 62K | 318K | 39K | 859K | 843.9K | |
| Interest Expense | 7.3M | 5.5M | 6.6M | 6.1M | 5.3M | 4.9M | |
| Total Revenue | 8.3M | 18.1M | 28.1M | 22.3M | 7.2M | 9.8M | |
| Gross Profit | (8.4M) | (3.2M) | 7.4M | 1.2M | (8.8M) | (8.4M) | |
| Other Operating Expenses | 60.4M | 59.5M | 71.0M | 77.8M | 54.3M | 55.3M | |
| Operating Income | (52.1M) | (41.4M) | (43.0M) | (55.5M) | (47.2M) | (49.5M) | |
| Ebit | (52.1M) | (41.4M) | (43.0M) | (55.5M) | (47.2M) | (49.5M) | |
| Research Development | 16.3M | 16.9M | 21.8M | 25.9M | 13.5M | 20.9M | |
| Ebitda | (51.7M) | (41.3M) | (42.7M) | (55.5M) | (46.3M) | (48.6M) | |
| Cost Of Revenue | 16.8M | 21.3M | 20.7M | 21.1M | 16.0M | 17.9M | |
| Total Operating Expenses | 43.6M | 38.2M | 50.3M | 56.7M | 38.3M | 43.2M | |
| Income Before Tax | (59.0M) | (46.8M) | (49.2M) | (62.3M) | (50.1M) | (52.6M) | |
| Total Other Income Expense Net | (6.9M) | (5.4M) | (6.3M) | (6.8M) | (2.9M) | (3.1M) | |
| Net Income | (63.1M) | (49.2M) | (53.5M) | (63.4M) | (50.1M) | (52.6M) | |
| Income Tax Expense | 4.1M | 2.4M | 4.3M | 1.1M | 1.2M | 1.2M | |
| Selling General Administrative | 27.3M | 21.3M | 28.5M | 30.6M | 26.1M | 26.0M | |
| Net Income From Continuing Ops | (59.0M) | (46.8M) | (49.2M) | (62.0M) | (49.8M) | (52.3M) | |
| Non Operating Income Net Other | 331K | 619K | 400K | 85K | 97.8K | 92.9K | |
| Net Income Applicable To Common Shares | (59.0M) | (46.8M) | (49.2M) | (62.6M) | (56.4M) | (59.2M) | |
| Interest Income | 7.3M | 14K | 112K | 8K | 7.2K | 6.8K | |
| Net Interest Income | (7.3M) | (5.5M) | (6.5M) | (6.1M) | (5.7M) | (6.0M) | |
| Reconciled Depreciation | 3.6M | 3.2M | 2.5M | 2.3M | 2.3M | 2.2M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards T2 Biosystms in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, T2 Biosystms' short interest history, or implied volatility extrapolated from T2 Biosystms options trading.
Currently Active Assets on Macroaxis
| LAAC | Lithium Americas Corp | |
| F | Ford Motor | |
| CHPT | ChargePoint Holdings | |
| AXL | American Axle Manufacturing | |
| ICLN | iShares Global Clean |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in T2 Biosystms. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Complementary Tools for TTOO Stock analysis
When running T2 Biosystms' price analysis, check to measure T2 Biosystms' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy T2 Biosystms is operating at the current time. Most of T2 Biosystms' value examination focuses on studying past and present price action to predict the probability of T2 Biosystms' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move T2 Biosystms' price. Additionally, you may evaluate how the addition of T2 Biosystms to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |
Is T2 Biosystms' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of T2 Biosystms. If investors know TTOO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about T2 Biosystms listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (19.19) | Revenue Per Share 2.756 | Quarterly Revenue Growth (0.69) | Return On Assets (0.85) | Return On Equity (6.22) |
The market value of T2 Biosystms is measured differently than its book value, which is the value of TTOO that is recorded on the company's balance sheet. Investors also form their own opinion of T2 Biosystms' value that differs from its market value or its book value, called intrinsic value, which is T2 Biosystms' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because T2 Biosystms' market value can be influenced by many factors that don't directly affect T2 Biosystms' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between T2 Biosystms' value and its price as these two are different measures arrived at by different means. Investors typically determine if T2 Biosystms is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, T2 Biosystms' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.